Cargando…
Hydroxychloroquine/lopinavir/ritonavir: Second-degree atrioventricular block (Mobitz II) with left bundle branch block and paroxysmal atrial fibrillation with bradycardia following off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990580/ http://dx.doi.org/10.1007/s40278-022-12945-y |
Ejemplares similares
-
Lopinavir/ritonavir: Third-degree atrioventricular block following off-label use: case report
Publicado: (2020) -
Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block
por: Khan, Alisha, et al.
Publicado: (2020) -
Hydroxychloroquine/lopinavir/ritonavir: Bradycardia and off-label-use: case report
Publicado: (2021) -
USE OF REMDESEVIR CAUSING SINUS BRADYCARDIA AND EVENTUALLY ASYMPTOMATIC MOBITZ TYPE 1 ATRIOVENTRICULAR BLOCK
por: Hossain, Afif, et al.
Publicado: (2022) -
Pseudo atrioventricular block most likely caused by junctional extrasystoles mimicking Mobitz II second degree atrioventricular block: A case report
por: Hollanda, Lucas, et al.
Publicado: (2020)